시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 로봇 바이오뱅크 시스템 시장 보고서(2025년)
Robotic Biobanking Systems Global Market Report 2025
상품코드 : 1889557
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,505,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,403,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,301,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

로봇 바이오뱅크 시스템 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 20억 달러로 평가되었고, 2025년에는 23억 달러에 달할 것으로 추정되며, CAGR 15.1%로 성장이 전망되고 있습니다. 지금까지의 성장은 효율적인 생물학적 샘플 관리에 대한 수요 증가, 생물의학 연구 활동의 양 증가, 바이오뱅크 및 바이오 리포지토리의 설립 확대, 맞춤형 의료에 대한 주목 증가, 임상시험 활동 증가에 기인한 것으로 보입니다.

로봇 바이오뱅크 시스템 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 39억 9,000만 달러에 달할 것으로 예측되며, CAGR 14.7%로 성장할 전망입니다. 예측 기간의 성장은 정밀의료 및 유전체 연구의 도입 확대, 실험실 워크플로우 내에서 자동화의 고급 통합, 대규모 집단 바이오뱅크 구상에 대한 수요 증가, 바이오마커 발견 및 트랜스레이셔널 리서치의 용도 확대, 데이터 중심 의료 의사 결정에 중점 강화와 관련됩니다. 예측 기간 동안 예상되는 주요 동향으로는 샘플 추적 및 예측 분석을 위한 인공지능(AI) 및 머신러닝 통합, 완전 자동화 저온 보존 시스템의 진보, 로봇 암의 정확성 및 편의성 향상, 사물 인터넷(IoT) 대응 모니터링 기술 도입, 클라우드 기반 바이오뱅킹 데이터 관리 플랫폼 채용 확대 등이 있습니다.

생물학적 샘플 수집량 증가는 향후 수년간 로봇 바이오뱅크 시스템 시장의 확대를 이끌 것으로 예측됩니다. 생물학적 샘플 수집이란 혈액, 조직, 타액, 기타 바이오 샘플 등의 재료를 체계적으로 수집 및 보존하고 관련 데이터와 함께 생물의학 연구, 진단, 치료 개발에 활용하는 것을 말합니다. 생물학적 샘플 수집 증가는 주로 정밀의료에 대한 수요 증가로 인한 것입니다. 현대의료는 유전체 연구, 바이오마커 발견, 개인화 치료 전략의 구축을 지원하기 위해 대규모의 상세한 특징을 지닌 생물학적 시료 저장소에 대한 의존도를 높이고 있습니다. 로봇 바이오뱅크 시스템은 시료의 취급, 보관, 검색을 자동화하고 시료량이 증가함에 따라 정밀도, 효율성 및 확장성을 확보함으로써 이 성장을 가속합니다. 예를 들어, 2025년 7월에는 영국을 거점으로 하는 대규모 생물의학 데이터베이스 'UK 바이오뱅크사'가 2026년에 1,100만 점 이상의 검체를 맨체스터의 신본사로 이전할 계획을 발표했습니다. 신시설에는 차세대 자동냉동고 4기가 설치되어 최대 2,000만 점의 검체를 보관 가능합니다. 로봇 시스템에 의한 시료 회수 능력은 연간 약 100만 점에 이르며 현행 시스템의 4배의 속도를 실현합니다. 이러한 생물학적 샘플 수집량 증가가 로봇 바이오뱅크 시스템 시장의 성장을 견인하고 있습니다.

로봇 바이오뱅크 시스템 시장의 주요 기업은 기술 능력 강화, 서비스 액세스 확대, 첨단 바이오뱅킹 워크플로우에서 자동화 도입 가속화를 목표로 한 전략적 제휴에 주력하고 있습니다. 이러한 제휴에는 기술 공급자, 의료기관, 연구기관 간의 파트너십이 포함되어 상호 강점을 활용하고, 혁신을 촉진하며, 업무 효율성을 개선하고, 시장 도달 범위를 확대하는 것을 목표로 하고 있습니다. 예를 들어, 2025년 10월에는 UAE에 본사를 둔 하이브리드 제대혈 은행인 아부다비 바이오뱅크가 UAE의 의료 제공업체인 NMC 헬스케어와 제휴하여 이 지역의 주요 병원에서 민간 및 공적 제대혈 은행 서비스의 액세스 확대를 도모했습니다. 본 협력은 로봇기술 및 자동화 바이오뱅크 시스템의 통합을 통해 맞춤형 의료와 줄기세포 연구를 지원합니다. 이 대처는 선진적인 로봇 처리 기술과 장기 자동 보존 기술을 기반으로 한 지역 최대급 제대혈 리포지토리의 구축을 목표로 하는 한편, 제대혈 보존의 이점에 관한 인지도 향상을 촉진하고, 장래의 생물의학 연구 및 재생 의료에의 공헌을 장려하는 것입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Robotic biobanking systems are automated, computer-controlled platforms designed to manage, process, and store biological specimens with high precision and minimal human intervention. These systems integrate robotics, artificial intelligence, and data management technologies to ensure accuracy, traceability, and long-term sample integrity within biorepositories. They are primarily used in biomedical research, clinical studies, and pharmaceutical development to streamline specimen handling and improve operational efficiency.

The key product types in robotic biobanking systems include automated sample storage systems, automated sample retrieval systems, automated sample processing systems, and others. Automated sample storage systems are technologically advanced, fully automated units designed to securely store, organize, and retrieve biological specimens with high precision and efficiency under controlled environmental conditions. Sample types include blood, tissue, cells, DNA/RNA, and others, stored across cryogenic, ambient, and refrigerated environments. These systems are used in applications such as clinical research, pharmaceutical and biotech research, academic and research institutions, and biobank management, serving end users including hospitals, research institutes, pharmaceutical and biotechnology companies, and contract research organizations (CROs).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The robotic biobanking systems market research report is one of a series of new reports from The Business Research Company that provides robotic biobanking systems market statistics, including robotic biobanking systems industry global market size, regional shares, competitors with a robotic biobanking systems market share, detailed robotic biobanking systems market segments, market trends and opportunities, and any further data you may need to thrive in the robotic biobanking systems industry. This robotic biobanking systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The robotic biobanking systems market size has grown rapidly in recent years. It will grow from $2.00 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. Growth in the historic period can be attributed to increasing demand for efficient biological sample management, rising volumes of biomedical research activities, the expanding establishment of biobanks and biorepositories, a growing focus on personalized medicine, and increased clinical trial activity.

The robotic biobanking systems market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. Growth in the forecast period can be linked to rising adoption of precision medicine and genomics research, greater integration of automation within laboratory workflows, growing demand for large-scale population biobanking initiatives, expanding applications in biomarker discovery and translational research, and heightened emphasis on data-driven healthcare decision-making. Major trends expected in the forecast period include the integration of artificial intelligence and machine learning for sample tracking and predictive analytics, advancements in fully automated cryogenic storage systems, improvements in robotic arm precision and dexterity, implementation of Internet of Things-enabled monitoring technologies, and increased adoption of cloud-based biobanking data management platforms.

The growing volume of biological sample collections is expected to drive the expansion of the robotic biobanking systems market in the coming years. Biological sample collections involve systematically gathering and preserving materials such as blood, tissue, saliva, or other biospecimens, along with related data, for use in biomedical research, diagnostics, and therapeutic development. The increase in biological sample collections is largely fueled by the rising demand for precision medicine, as modern healthcare increasingly relies on large, well-characterized biospecimen repositories to support genomic research, biomarker discovery, and the creation of personalized treatment strategies. Robotic biobanking systems facilitate this growth by automating the handling, storage, and retrieval of samples, ensuring accuracy, efficiency, and scalability as sample volumes rise. For example, in July 2025, UK Biobank Limited, a UK-based large-scale biomedical database, announced plans to relocate over 11 million samples to its new Manchester headquarters in 2026. The facility will house four next-generation automated freezers capable of storing up to 20 million samples, with robotic systems retrieving approximately 1 million samples annually-four times faster than the current capacity. As a result, the rising volume of biological sample collections is propelling the growth of the robotic biobanking systems market.

Leading companies in the robotic biobanking systems market are focusing on strategic collaborations to enhance technological capabilities, expand service accessibility, and accelerate the adoption of automation in advanced biobanking workflows. Such collaborations involve partnerships between technology providers, healthcare institutions, and research organizations to leverage complementary strengths, foster innovation, improve operational efficiency, and increase market reach. For instance, in October 2025, Abu Dhabi Biobank, a UAE-based hybrid cord blood bank, partnered with NMC Healthcare, a UAE healthcare provider, to expand access to private and public cord blood banking services across major hospitals in the region. The collaboration supports personalized healthcare and stem cell research through the integration of robotic and automated biobanking systems. The initiative aims to establish one of the region's largest cord blood repositories, supported by advanced robotic handling and long-term automated storage technologies, while promoting awareness of the benefits of cord blood preservation and encouraging contributions to future biomedical research and regenerative medicine.

In July 2025, Hamilton Company, a Switzerland-based provider of liquid handling, process analytics, robotics, and automated storage solutions, acquired UK Robotics and Trisonic Discovery for an undisclosed sum. This acquisition enables Hamilton to strengthen its laboratory automation capabilities by integrating advanced scheduling software, system integration expertise, and precision acoustic dispensing technologies to deliver fully automated, scalable research workflows. UK Robotics and Trisonic Discovery are UK-based providers specializing in robotic biobanking systems.

Major companies operating in the robotic biobanking systems market are Thermo Fisher Scientific Inc., Siemens Healthineers AG, Roche Diagnostics Inc., Beckman Coulter Inc., Qiagen N.V., Tecan Group Ltd., Hamilton Company, Azenta Life Sciences, Haier Biomedical Co., BICO, Gilson Inc., SPT Labtech Ltd., B Medical Systems S.a.r.l, MGI Tech Co. Ltd., HighRes Biosolutions Inc., LiCONiC AG, ASKION GmbH, SciRobotics Ltd., Andrew Alliance SA, Angelantoni Life Science Srl.

North America was the largest region in the robotic biobanking systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in robotic biobanking systems report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the robotic biobanking systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The robotic biobanking systems market consists of sales of automated tube decapping systems, automated capping and recapping systems, robotic plate handling systems, automated liquid handling systems, and sample identification and scanning modules. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Robotic Biobanking Systems Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on robotic biobanking systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for robotic biobanking systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The robotic biobanking systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Robotic Biobanking Systems Market Characteristics

3. Robotic Biobanking Systems Market Trends And Strategies

4. Robotic Biobanking Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Robotic Biobanking Systems Growth Analysis And Strategic Analysis Framework

6. Robotic Biobanking Systems Market Segmentation

7. Robotic Biobanking Systems Market Regional And Country Analysis

8. Asia-Pacific Robotic Biobanking Systems Market

9. China Robotic Biobanking Systems Market

10. India Robotic Biobanking Systems Market

11. Japan Robotic Biobanking Systems Market

12. Australia Robotic Biobanking Systems Market

13. Indonesia Robotic Biobanking Systems Market

14. South Korea Robotic Biobanking Systems Market

15. Western Europe Robotic Biobanking Systems Market

16. UK Robotic Biobanking Systems Market

17. Germany Robotic Biobanking Systems Market

18. France Robotic Biobanking Systems Market

19. Italy Robotic Biobanking Systems Market

20. Spain Robotic Biobanking Systems Market

21. Eastern Europe Robotic Biobanking Systems Market

22. Russia Robotic Biobanking Systems Market

23. North America Robotic Biobanking Systems Market

24. USA Robotic Biobanking Systems Market

25. Canada Robotic Biobanking Systems Market

26. South America Robotic Biobanking Systems Market

27. Brazil Robotic Biobanking Systems Market

28. Middle East Robotic Biobanking Systems Market

29. Africa Robotic Biobanking Systems Market

30. Robotic Biobanking Systems Market Competitive Landscape And Company Profiles

31. Robotic Biobanking Systems Market Other Major And Innovative Companies

32. Global Robotic Biobanking Systems Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Robotic Biobanking Systems Market

34. Recent Developments In The Robotic Biobanking Systems Market

35. Robotic Biobanking Systems Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기